{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:08:00Z","timestamp":1790762880375,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00554","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:25:22Z","timestamp":1562675122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Biomarkers in Inflammatory Myopathies\u2014An Expanded Definition"],"prefix":"10.3389","volume":"10","author":[{"given":"Olivier","family":"Benveniste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Hilmar","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","article-title":"Advances in serological diagnostics of inflammatory myopathies","volume":"29","author":"Benveniste","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","article-title":"Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy","volume":"84","author":"Stenzel","year":"2015","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1093\/brain\/aww125","article-title":"Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1","volume":"139","author":"Uruha","year":"2016","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1515\/cclm-2018-0807","article-title":"Standardization and harmonization of autoimmune diagnostics","volume":"56","author":"Jacobs","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053","article-title":"Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases","volume":"117","author":"Tozzoli","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13317-017-0098-1","article-title":"Personalized medicine in rheumatology: the paradigm of serum autoantibodies","volume":"8","author":"Sirotti","year":"2017","journal-title":"Auto Immun Highlights"},{"key":"B16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12385","article-title":"Myopathology in times of modern imaging","volume":"43","author":"Jungbluth","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/1874312901206010054","article-title":"Laboratory test abnormalities are common in polymyositis and dermatomyositis and differ among clinical and demographic groups","volume":"6","author":"Volochayev","year":"2012","journal-title":"Open Rheumatol J"},{"key":"B21","first-page":"64","article-title":"Characterization of inflammatory responses to eccentric exercise in humans","volume":"11","author":"Peake","year":"2005","journal-title":"Exerc Immunol Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1152\/japplphysiol.00971.2016","article-title":"Muscle damage and inflammation during recovery from exercise","volume":"122","author":"Peake","year":"2017","journal-title":"J Appl Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/apha.12844","article-title":"Neuromuscular changes and the rapid adaptation following a bout of damaging eccentric exercise","volume":"220","author":"Goodall","year":"2017","journal-title":"Acta Physiol"},{"key":"B24","first-page":"133","article-title":"Muscle enzyme release does not predict muscle function impairment after triathlon","volume":"39","author":"Margaritis","year":"1999","journal-title":"J Sports Med Phys Fitness"},{"key":"B25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1515\/CCLM.2009.127","article-title":"Serum enzyme profile characteristics of victims following the Wenchuan earthquake in China","volume":"47","author":"Feng","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"B26","first-page":"225","article-title":"The myopathic effects of electrical injury","volume":"16","author":"Aygun","year":"2010","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/ard.59.4.257","article-title":"Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"59","author":"Bandoh","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1548918","article-title":"Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis","volume":"19","author":"Nishioka","year":"2018","journal-title":"Mod Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2169\/internalmedicine.8335-16","article-title":"The serum ferritin level is associated with the treatment responsivity for rapidly progressive interstitial lung disease with amyopathic dermatomyositis, irrespective of the anti-MDA5 antibody level","volume":"57","author":"Osawa","year":"2018","journal-title":"Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3899\/jrheum.090562","article-title":"Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies","volume":"36","author":"Aggarwal","year":"2009","journal-title":"J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/0140-6736(92)92262-E","article-title":"Serum cardiac troponin T in polymyositis\/dermatomyositis","volume":"340","author":"Kobayashi","year":"1992","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00415-009-5350-9","article-title":"The heart in sporadic inclusion body myositis: a study in 51 patients","volume":"257","author":"Cox","year":"2010","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nmd.2006.06.006","article-title":"Raised troponin T in inclusion body myositis is common and serum levels are persistent over time","volume":"16","author":"Lindberg","year":"2006","journal-title":"Neuromusc Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Suarez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Suarez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.24847","article-title":"Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis","volume":"81","author":"Guttsches","year":"2017","journal-title":"Ann Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"Greenberg","year":"2012","journal-title":"Genes Immun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/brain\/awy105","article-title":"JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis","volume":"141","author":"Ladislau","year":"2018","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JND-140054","article-title":"Diagnostic utility of auto-antibodies in inflammatory muscle diseases","volume":"2","author":"Allenbach","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ensci.2018.05.004","article-title":"Anti-mitochondrial antibody-associated myositis with eosinophilia and dropped head","volume":"11","author":"Shimizu","year":"2018","journal-title":"eNeurologicalSci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"Immune-mediated necrotizing myopathies working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2017","journal-title":"Neuromusc Disord"},{"key":"B58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromusc Disord"},{"key":"B59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromusc Disord"},{"key":"B60","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","article-title":"Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression","volume":"186","author":"Allenbach","year":"2016","journal-title":"Am J Pathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12519","article-title":"Diagnostic potential of sarcoplasmic MxA expression in subsets of dermatomyositis","author":"Uruha","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","article-title":"Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy","volume":"2","author":"Aouizerate","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study","volume":"87","author":"Hida","year":"2016","journal-title":"Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","article-title":"Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis","volume":"4","author":"Preusse","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"key":"B66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(89)90228-1","article-title":"Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle","volume":"94","author":"de Visser","year":"1989","journal-title":"J Neurol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e004552","DOI":"10.1136\/bmjopen-2013-004552","article-title":"A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis","volume":"4","author":"Brady","year":"2014","journal-title":"BMJ Open"},{"key":"B69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":"p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00401-010-0737-3","article-title":"Novel demonstration of amyloid-beta oligomers in sporadic inclusion-body myositis muscle fibers","volume":"120","author":"Nogalska","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nan.12384","article-title":"Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy","volume":"43","author":"Weihl","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"Lopez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.21822","article-title":"Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features","volume":"54","author":"Pestronk","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:25:26Z","timestamp":1562675126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":73,"alternative-id":["10.3389\/fneur.2019.00554"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00554","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"article-number":"554"}}